Rhabdomyoblasts in Pediatric Tumors: A Review with Emphasis on their Diagnostic Utility
Article Sidebar
Main Article Content
Abstract
Rhabdomyosarcoma is a soft tissue pediatric sarcoma composed of cells which show morphological, immunohistochemical and ultrastructural evidence of skeletal muscle differentiation. To date four major subtypes have been recognized: embryonal, alveolar, spindle cell/sclerosing and pleomorphic. All these subtypes are defined, at least in part, by the presence of rhabdomyoblasts, i.e. cells with variable shape, densely eosinophilic cytoplasm with occasional cytoplasmic cross-striations and eccentric round nuclei. It must be remembered, however, that several benign and malignant pediatric tumours other than rhabdomyosarcoma may exhibit rhabdomyoblaststic and skeletal muscle differentiation. This review focuses on the most common malignant pediatric neoplasm that may exhibit rhabdomyoblastic differentiation, with an emphasis on the most important clinicopathological and differential diagnostic considerations.
Article Details
Copyright (c) 2017 Angelico G, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Stem Cell Therapy and Transplantation is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Journal of Stem Cell Therapy and Transplantation is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Parham DM, Barr FG. Classification of rhabdomyosarcoma and its molecular basis. Adv Anat Pathol. 2013; 20: 387-397. Ref.: https://goo.gl/sUAFuX
Parham DM, Ellison DA. Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med. 2006; 130: 1454-1465. Ref.: https://goo.gl/S8vwk7
Miettinen M, Fetsch JF, Antonescu CR. Tumors with skeletal muscle differentiation. AFIP atlas of tumor pathology: tumors of the soft tissues. Silver Spring: ARP Press. 2014; 289-308.
Woodruff JM, Perino G. Non-germ-cell or teratomatous malignant tumors showing additional rhabdomyoblastic differentiation, with emphasis on the malignant Triton tumor. Semin Diagn Pathol. 1994; 11: 69-81. Ref.: https://goo.gl/rg8lUB
Fletcher CDM. Spindle cell/sclerosing rhabdomyosarcoma. World Health Organization (WHO) classification of tumours of soft tissue and bone. Vol 5. Fourth Edn. IARC press: France, Lyon, 2013; 468.
Qualman SJ, Coffin CM, Newton WA, Hojo H, Triche TJ, et al. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol. 1998; 1: 550-61. Ref.: https://goo.gl/PS6z00
Cavazzana AO, Schmidt D, Ninfo V, Harms D, Tollot M, et al. Spindle cellrhabdomyosarcoma. A prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol. 1992; 16: 229-235. Ref.: https://goo.gl/UzGfAW
Folpe AL, McKenney JK, Bridge JA, Weiss SW. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol. 2002; 26: 1175-1183. Ref.: https://goo.gl/4ipwjA
Rekhi B, Upadhyay P, Ramteke MP, Dutt A. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes. Mod Pathol. 2016; 29: 1532-1540. Ref.: https://goo.gl/be0R7M
Mungan S, Arslan S, Küçüktülü E, Ersöz Ş, Çobanoğlu B. Pleomorphic Rhabdomyosarcoma Arising from True Vocal Fold of Larynx: Report of a Rare Case and Literature Review. Case Rep Otolaryngol. 2016; 2016: 8135967. Ref.: https://goo.gl/6E9E7H
Rudzinski ER, Anderson JR, Lyden ER, Bridge JA, Barr FG, et al. Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group. Am J Surg Pathol. 2014; 38: 654-659. Ref.: https://goo.gl/44GfNS
Miki H, Kobayashi S, Kushida Y, Sasaki M, Haba R, et al. A case of infantile rhabdomyofibrosarcoma with immunohistochemical, electronmicroscopical, and genetic analyses. Hum Pathol. 1999; 30: 1519-1522. Ref.: https://goo.gl/XrNi6K
Lundgren L, Angervall L, Stenman G, Kindblom LG. Infantile rhabdomyofibrosarcoma: a high-grade sarcoma distinguishable from infantile fibrosarcoma and rhabdomyosarcoma. Hum Pathol. 1993; 24: 785-795. Ref.: https://goo.gl/KmOrQD
Stasik CJ, Tawfik O. Malignant peripheral nerve sheath tumor with rhabdomyosarcomatous differentiation (malignant triton tumor). Arch Pathol Lab Med. 2006, 130: 1878-1881. Ref.: https://goo.gl/8BLODr
Durbin AD, Ki DH, He S, Look AT. Malignant Peripheral Nerve Sheath Tumors. Adv Exp Med Biol. 2016; 916: 495-530. Ref.: https://goo.gl/n8eirv
Masson P. Recklinghausen’s neurofibromatosis, sensory neuromas and motor neuromas. In: Libman Anniversary. Vol 2. New York, NY: International Press. 1932: 793-802.
Woodruff JM, Perino G. Non-germ-cell or teratomatous malignant tumors showing additional rhabdomyoblastic differentiation, with emphasis on the malignant triton tumor. Semin Diagn Pathol. 1994; 11: 69-81. Ref.: https://goo.gl/rTiRHj
Karcioglu Z, Someren A, Mathes SJ. Ectomesenchymoma. A malignant tumor of migratory neural crest (ectomesenchyme) remnants showing ganglionic, schwannian, melanocytic and rhabdomyoblastic differentiation. Cancer. 1977; 39: 2486-2496. Ref.: https://goo.gl/dR4vdr
Huang SC, Alaggio R, Sung YS, Chen CL, Zhang L, et al. Frequent HRAS Mutations in Malignant Ectomesenchymoma: Overlapping Genetic Abnormalities with Embryonal Rhabdomyosarcoma. Am J Surg Pathol. 2016; 40: 876-885. Ref.: https://goo.gl/cbhfNV
Chau YY, Hastie ND. The role of Wt1 in regulating mesenchyme in cancer, development, and tissue homeostasis. Trends Genet. 2012; 28: 515-524. Ref.: https://goo.gl/gBcxA1
Salvatorelli L, Parenti R, Leone G, Musumeci G, Vasquez E, et al. Wilms tumor 1 (WT1) protein: Diagnostic utility in pediatric tumors. Acta Histochem. 2015; 117: 367-378. Ref.: https://goo.gl/Cy7A8U
Tu BW, Ye WJ, Li YH. Botryoid Wilms' tumor: report of two cases. World J Pediatr. 2011; 7: 274-276. Ref.: https://goo.gl/enFS3P
Carpentieri DF, Nichols K, Chou PM, Matthews M, Pawel B, et al. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Mod Pathol. 2002; 15: 1080-1086. Ref.: https://goo.gl/JH5dM6
Pollono D, Drut R, Tomarchio S, Fontana A, Ibañez O. Fetal rhabdomyomatous nephroblastoma: report of 14 cases confirming chemotherapy resistance. J Pediatr Hematol Oncol. 2003; 25: 640-643. Ref.: https://goo.gl/NKaglc
Irtan S, Ehrlich PF, Pritchard-Jones K. Wilms tumor: "State-of-the-art" update, 2016. Semin Pediatr Surg. 2016; 25: 250-256. Ref.: https://goo.gl/nKgxCA
Cone EB, Dalton SS, Van Noord M, Tracy ET, Rice HE, et al. Biomarkers for Wilms Tumor: A Systematic Review. J Urol. 2016; 196: 1530-1535. Ref.: https://goo.gl/8XxcXX
Fosdal MB. Pleuropulmonary blastoma. J Pediatr Oncol Nurs. 2008; 25: 295-302. Ref.: https://goo.gl/AFy4I5
Mehraein Y, Schmid I, Eggert M, Kohlhase J, Steinlein OK. DICER1 syndrome can mimic different genetic tumor predispositions. Cancer Lett. 2016; 370: 275-278. Ref.: https://goo.gl/rFlSyv
Hill DA, Jarzembowski JA, Priest JR, Williams G, Schoettler P, et al. Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol. 2008; 32: 282-295. Ref.: https://goo.gl/W3ANsO
Sciot R, Dal Cin P, Brock P, Moerman P, Van Damme B, et al. Pleuropulmonary blastoma (pulmonary blastoma of childhood): genetic link with other embryonal malignancies? Histopathology. 1994; 24: 559-563. Ref.: https://goo.gl/XjHWbI
Indolfi P, Bisogno G, Casale F, Cecchetto G, De Salvo G, et al. Prognostic factors in pleuro-pulmonary blastoma. Pediatr Blood Cancer. 2007; 48: 318-23. Ref.: https://goo.gl/1HwiOh